OPN-375 Efficacy and Safety in Adolescents With Bilateral Nasal Polyps

Recruiting

Phase 3

OPN-375OPN-375 Efficacy and Safety in Adolescents With Bilateral Nasal Polyps

Sponsor:

Optinose US Inc.

Code:

NCT03747458

Conditions

Bilateral Nasal Polyposis

Eligibility Criteria

Sex: All

Age: 12 - 17

Healthy Volunteers: Not accepted

Interventions

OPN-375

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-08-19. This information was provided to ClinicalTrials.gov by Optinose US Inc. on 2023-09-26.